Ryan Daniels

Do you think that will have any cannibalization on the reference lab?

if you could talk a little bit about your expectations for that, both in regards to helping lab growth

You mentioned some supply chain disruption impacting, I think, international growth

we've seen somewhat of an inflection towards positive non-wellness visits. I'm curious if you've dug into that any deeper?

Can you go a little bit more in depth about some of the investments you're making in the sales force

curious if there's anything that surprised you about how it's being used either as part of a broader panel at a lower price